Combivir

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company:

Approval Status:

Approved September 1997

Specific Treatments:

AIDS, HIV Infection

Find Related Trials for The Following Conditions

General Information

The U.S. Food and Drug Administration approved the first one-pill combination of the two most widely used antiretroviral medications for AIDS and HIV infection. Combivir, a combination of Retrovir (zidovudine or AZT) and Epivir (lamivudine or 3TC), could decrease the number of pills people with HIV have to take daily.

Side Effects

Side effects include: nausea, diarrhea, anemia, low white blood cells, pancreatitis and neuropathy.